Comparison 33. PERPHENAZINE vs ZUCLOPENTHIXOL.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Leaving the study early: 1. Any reason	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.8 [0.69, 4.67]
2 Global state: 1. Change over time ‐ no better or deterioration (ITT)	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
2.1 short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.0 [0.07, 15.18]
3 Adverse events: Movement disorders	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
3.1 akathisia ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.14 [0.48, 2.71]
3.2 akinesia ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	0.33 [0.07, 1.51]
3.3 rigidity ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	2.2 [0.88, 5.48]
3.4 tremor ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	2.2 [0.88, 5.48]
4 Other adverse events: 1. Arousal	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
4.1 excitation ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.29 [0.56, 2.95]
4.2 insomnia ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	0.33 [0.07, 1.51]
4.3 sleepiness/sedation ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.71 [0.80, 3.68]
5 Other adverse events: 2. Cardiovascular	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
5.1 faintness, dizziness, weakness ‐ short term	1	54	Risk Ratio (M‐H, Random, 95% CI)	1.5 [0.48, 4.72]